Physician profile
Amanda Perry
NPI 1497872733
$744.91
in general payments reported to CMS, 2019-2025
18 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $112 · 2023: $246 · 2024: $125 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $282.03 | 2021-2024 | Bexsero, Pediarix, Rotarix |
| Sanofi Pasteur INC. | $57.38 | 2023-2025 | |
| Abbott Laboratories | $44.97 | 2023-2024 | Proclaim, Eterna |
| Takeda Pharmaceuticals U.S.A., INC. | $41.59 | 2021-2025 | Elaprase |
| Merck Sharp & Dohme LLC | $41.19 | 2022-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Pfizer INC. | $30.99 | 2021-2022 | |
| Ars Pharmaceuticals Operations, INC. | $29.13 | 2025 | Neffy |
| Ucb, INC. | $27.45 | 2024 | Briviact |
| Eagle Pharmaceuticals, INC. | $26.73 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $24.09 | 2023 | Flumist Quadrivalent |
| Corium, LLC | $20.49 | 2022 | |
| Tris Pharma INC | $19.52 | 2021 | |
| Nevro Corp. | $18.53 | 2023 | Senza |
| Acadia Pharmaceuticals INC | $17.55 | 2025 | Nuplazid |
| Neos Therapeutics, LP | $16.97 | 2024 | Cotempla Xr-Odt |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $16.74 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.99 | 2025 | Jornay Pm |
| Nestle Healthcare Nutrition INC. | $13.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.